Miyazaki Y, Matsumura I, Arita T, Fukuda R, et al. Post-marketing surveillance of quizartinib for relapsed or refractory FLT3-ITD-positive acute myeloid leukemia in Japan. Int J Hematol 2026 Feb 26. doi: 10.1007/s12185-026-04181.
PMID: 41746494